MDA-MB-231 breast cancer cells resistant to pleurocidin-family lytic peptides are chemosensitive and exhibit reduced tumor-forming capacity

Ashley L. Hilchie, Erin E. Gill, Melanie R. Power Coombs, Reza Falsafi, Robert E.W. Hancock, David W. Hoskin

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
Original languageEnglish
Article number1220
Pages (from-to)1-16
Number of pages16
JournalBiomolecules
Volume10
Issue number9
DOIs
Publication statusPublished - Sept 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Molecular Biology
  • Biochemistry

Keywords

  • Anticancer peptide
  • Breast cancer
  • Cytolysis
  • Peptide-resistance
  • Pleurocidin

Fingerprint

Dive into the research topics of 'MDA-MB-231 breast cancer cells resistant to pleurocidin-family lytic peptides are chemosensitive and exhibit reduced tumor-forming capacity'. Together they form a unique fingerprint.

Cite this